CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
T-cell cytokine pattern in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 173s Year: 2002
Perforin expression and lymphocytes adhesion molecules in patients with pulmonary sarcoidosis Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005
Cytokine and protein profile in BAL from patients with sarcoidosis and IPF Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001
Serum levels of IL-10 and IL-12 i patients with pulmonary sarcoidosis Source: Annual Congress 2009 - Inflammation and airways Year: 2009
Main features of cytokine profile in serum and bronchoalveolar lavage fluid in patients with recurrent sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013
Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007
Clinical implications of CCR5 expression and IL-2 secretion in bronchoalveolar lavage fluid in sarcoidosis Source: Annual Congress 2008 - Asthma: mechanisms and treatment Year: 2008
Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012
Relationship between IL-8, IL-10, MMP-9 and morphological findings in BAL fluid of patients with interstitial lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 225s Year: 2003
Concentration of IL-2, IL-4, IL-8 and TNF in blood serum and sputum in bronchial asthma and chronic obstructive pulmonary disease Source: Annual Congress 2009 - Inflammation and airways Year: 2009
Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005
Analysis of cellular components of bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis and pulmonary sarcoidosis: focus on lymphocyte and macrophage subpopulations Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008
Th1/Th2 and Tc1/Tc2 profiles in bronchoalveolar lavage and sputum induction in pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 107s Year: 2001
Evaluation in bronchoalveolar lavage fluid (BALF) of cytokines TNF-alpha, IL-6 and IL-8 in children with severe bronchial asthma (BA) Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010
Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006
Investigation of cellularity and the cytokines profile of bronchoalveolar lavage in sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 255s Year: 2003
Th1/Th2/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis in relation to smoking Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012
CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2002; 20: Suppl. 38, 598s Year: 2002
Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001